Inspire Medical Systems, Inc. 8-K

What Happened

• Inspire Medical Systems, Inc. (INSP) reported in an 8-K filed May 5, 2026 that its stockholders approved an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan (the A&R 2018 Plan) at the company’s 2026 Annual Meeting. The approval authorizes a total of 9,903,857 shares for awards (including a 2,600,000‑share increase above the prior reserve). The A&R 2018 Plan is described in the Definitive Proxy Statement filed March 20, 2026 and is attached as Exhibit 10.1 to the 8-K.

Key Details

• Authorized shares for awards: 9,903,857 total (7,303,857 previously authorized plus 2,600,000 new shares).
• Evergreen feature removed: the prior plan’s automatic annual share increase was eliminated.
• Vesting and dividend limits: minimum one‑year vesting on awards (with limited exceptions); dividends/dividend equivalents may not be paid on unvested time‑based awards (performance-based awards were already restricted).
• Plan term extended through March 6, 2036 (the tenth anniversary of Board approval).

Why It Matters

• The approval creates an explicit pool of up to 9.9 million shares that can be issued for equity compensation, which could increase the company’s outstanding share count if and when awards are granted and vest.
• Removing the evergreen feature limits automatic long‑term dilution growth of the share reserve, while the new minimum vesting and dividend restrictions align award payouts more closely with vesting and performance.
• The extension through 2036 ensures the company has an approved equity plan in place for compensation and retention purposes; the full terms are in Exhibit 10.1 and the March 20, 2026 proxy filing for investors to review.